Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2019-01-23 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Director Declaration
Regulatory Filings Classification · 98% confidence The document is very short (1721 characters) and is explicitly marked with an 'RNS Number'. The content announces a change in a Non-Executive Director's role at another company, which is a mandatory disclosure under Listing Rule 9.6.14(2). This type of announcement, which is a specific regulatory disclosure but not a comprehensive report (like 10-K or IR), fits best under the general 'Regulatory Filings' category (RNS) or potentially 'Board/Management Information' (MANG). Since the text is a direct regulatory notification provided via the RNS service, and it concerns a director's appointment elsewhere (not a resignation/appointment within the reporting company, which would be MANG), RNS is the most appropriate general classification for this type of mandatory, brief regulatory update that doesn't fit a more specific financial report category. Given the options, RNS serves as the best fit for a standard, brief regulatory news service announcement.
2019-01-23 English
Trading Update & Notice of Interim Results
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing 'Additional information' via 'RNS, the news service of the London Stock Exchange'. The content is a 'Trading Update' for the half-year period (1 July to 31 December 2018) and includes key financial highlights, operational reviews, and a notice about the upcoming Interim Results announcement date (25 February 2019). This structure—a brief update on recent performance released via an official news service—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key highlights and performance metrics for a specific period, it fits the definition of an Earnings Release (ER). However, because it is explicitly distributed via RNS and is a concise update rather than the full comprehensive report (which is announced for Feb 25), it also strongly aligns with the general regulatory announcement category. Given the presence of 'RNS Number' and the explicit mention of RNS as the provider, and the fact that it is a concise trading update, classifying it as a general Regulatory Filing (RNS) is appropriate, although it contains ER elements. Since the document is short and distributed via RNS, and it is a 'Trading Update' rather than the full 'Interim Results', RNS is the most fitting general category for this type of market communication distributed through the LSE's service. H1 2019
2019-01-14 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly states 'RNS Number : 3135L' and references compliance with 'DTR 5.6.1R' (Disclosure and Transparency Rules), which are hallmarks of regulatory announcements made via the London Stock Exchange's RNS system. The content specifically details the 'Total Voting Rights' as of a certain date (102,553,691 shares), which is a mandatory disclosure under transparency rules for shareholders. While this relates to voting rights, it is a specific regulatory notification rather than a general AGM result (DVA) or a proxy solicitation document (PSI). Given the context of being an RNS announcement providing specific regulatory data, the most appropriate general category for mandatory, non-standardized regulatory updates is RNS, as it is explicitly branded as an RNS release and serves as a primary information provider notification.
2018-12-31 English
Half-Yearly Financial Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Yearly Financial Report 2019' and covers the six-month period ended 31 December 2018. It contains comprehensive financial statements, operational reviews, and detailed financial summaries (revenue, operating profit, EPS, etc.). It is a substantive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2018-12-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Aviva plc regarding their interest in Dechra Pharmaceuticals plc. This is a regulatory disclosure form used to report when a shareholder's interest crosses a specific threshold (in this case, moving to 3%). This fits the definition of a 'Major Shareholding Notification'.
2018-12-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled as an 'RNS Number' notification from the London Stock Exchange. The content is a 'TR-1: Standard form for notification of major holdings' concerning Aviva plc's stake in Dechra Pharmaceuticals plc, detailing changes in voting rights and financial instruments. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific and appropriate classification for a TR-1 form.
2018-12-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.